title: Cost-effectiveness of adenotonsillectomy in reducing obstructive sleep apnea, cerebrovascular ischemia, vaso-occlusive pain, and ACS episodes in pediatric sickle cell disease.
abstract: In children with sickle cell disease (SCD), adenotonsillar hypertrophy or recurrent tonsillitis are frequently linked with an increased risk of obstructive sleep apnea, cerebrovascular ischemia, or frequent pain episodes and often require an adenoidectomy and/or tonsillectomy. Interventions designed to prevent these complications, control vaso-occlusive pain episodes, and avoid hospitalizations may reduce the significant personal and economic burden of SCD. This study compares episode recurrence and treatment costs for cerebrovascular ischemia, vaso-occlusive pain, acute chest syndrome (ACS), and obstructive sleep apnea in children who had an adenotonsillectomy (A/T surgery, N = 256; 11.7%) and a matched cohort of those who did not (N = 512; 23.3%) from a cohort of 2,194 children and adolescents with SCD from South Carolina's Medicaid system. A/T surgery was associated with a significantly reduced rate of visits over time for obstructive sleep apnea and cerebrovascular ischemia (e.g., stroke, transient ischemic attacks), but not with any change in the rate of visits for vaso-occlusive pain or ACS/pneumonia visits. The rate of mean acute (emergency and inpatient) service costs was significantly decreasing over time after an increase about the time the A/T surgery was performed. The cost-effectiveness of adenoidectomy and/or tonsillectomy for treating obstructive sleep apnea and preventing cerebrovascular ischemia without increasing vaso-occlusive pain episodes or long-term acute service costs in routine clinical practice settings was demonstrated. The matched control group of SCD patients without A/T surgery contained more patients with severe vaso-occlusive pain episodes, ACS visits, and higher mean total costs over time and appears to represent a different phenotype of children with SCD.
authors: Department of Epidemiology and Biostatistics, University of South Carolina Arnold School of Public Health, Columbia, SC, USA.
authors: Avnish
authors: A
authors: Tripathi
authors: Jeanette M
authors: JM
authors: Jerrell
authors: James R
authors: JR
authors: Stallworth
mesh_terms: D056586:Acute Chest Syndrome / Q000191:economics / Q000209:etiology / Q000517:prevention & control* / Q000601:surgery; D000233:Adenoidectomy / Q000191:economics*; D000293:Adolescent; D000755:Anemia, Sickle Cell / Q000150:complications / Q000191:economics / Q000601:surgery; D002545:Brain Ischemia / Q000191:economics / Q000209:etiology / Q000517:prevention & control* / Q000601:surgery; D002648:Child; D003362:Cost-Benefit Analysis; D005006:Ethnicity; D005260:Female; D017048:Health Care Costs / Q000706:statistics & numerical data*; D006801:Humans; D008297:Male; D008484:Medicaid; D010146:Pain / Q000191:economics / Q000209:etiology / Q000517:prevention & control / Q000601:surgery; D012008:Recurrence; D020181:Sleep Apnea, Obstructive / Q000191:economics / Q000209:etiology / Q000517:prevention & control* / Q000601:surgery; D013022:South Carolina; D014068:Tonsillectomy / Q000191:economics*; D016896:Treatment Outcome; D014481:United States